KR900014308A - 비스펜에탄올아민 - Google Patents

비스펜에탄올아민 Download PDF

Info

Publication number
KR900014308A
KR900014308A KR1019900002803A KR900002803A KR900014308A KR 900014308 A KR900014308 A KR 900014308A KR 1019900002803 A KR1019900002803 A KR 1019900002803A KR 900002803 A KR900002803 A KR 900002803A KR 900014308 A KR900014308 A KR 900014308A
Authority
KR
South Korea
Prior art keywords
compound according
chlorophenethyl
obesity
bis
hydroxy
Prior art date
Application number
KR1019900002803A
Other languages
English (en)
Inventor
알리크 레오
뮐러 마르셀
Original Assignee
쟝-자크 오가이, 룰란트 보러
에프. 호프만-라 로슈 에이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쟝-자크 오가이, 룰란트 보러, 에프. 호프만-라 로슈 에이지 filed Critical 쟝-자크 오가이, 룰란트 보러
Publication of KR900014308A publication Critical patent/KR900014308A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

내용 없음

Description

비스펜에탄올아민
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 4-〔2-〔비스〔(R)-β-하이드록시-3-클로로펜에틸〕아미노〕에틸〕페녹시에탄올 및 생리학적으로 허용되는 이의 염.
  2. 제1항에 있어서, 특히 비만증, 당뇨병 및 고단백질 분해와 관련된 상태의 치료를 위한 치료학적 활성 물질로서의 화합물.
  3. 특히 비만증, 당뇨병 및 고단백질 분해와 관련된 상태의 치료를 위한, 제1항에 따른 화합물을 함유하는 약제학적 제재.
  4. 제1항에 따른 화합물을 함유하는, 동물을 비만화시키기 위한 사료.
  5. 4-〔2-〔비스〔(R)-β-하이드록시-3-클로로펜에틸〕아미노〕에틸〕페녹시에탄올에 상응하는 페놀, 4-〔2-〔비스〔(R)-β-하이드록시-3-클로로펜에틸〕아미노〕에틸〕페놀을 2-하이드록시에틸 그룹을 도입시키는 시약으로 에테르화시키고, 필요할 경우 수득된 화합물을 염으로 전환시킴을 특징으로 하여, 제1항에 따른 화합물을 제조하는 방법.
  6. 비만증, 당뇨병 및 고단백질 분해와 관련된 상태의 치료용 약제학적 제제를 제조하기 위한 제1항에 따른 화합물의 용도.
  7. 제5항의 방법 또는 이와 화학적으로 명백히 균등한 방법으로 제조된 제1항의 화합물.
  8. 특히 실시예를 참조로 상기 기술한 바와 같은 화합물, 방법, 제제 및 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900002803A 1989-03-07 1990-03-05 비스펜에탄올아민 KR900014308A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH841/89-4 1989-03-07
CH84189 1989-03-07

Publications (1)

Publication Number Publication Date
KR900014308A true KR900014308A (ko) 1990-10-23

Family

ID=4196454

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900002803A KR900014308A (ko) 1989-03-07 1990-03-05 비스펜에탄올아민

Country Status (12)

Country Link
EP (1) EP0386603A3 (ko)
JP (1) JPH02279659A (ko)
KR (1) KR900014308A (ko)
AU (1) AU5061490A (ko)
CA (1) CA2010638A1 (ko)
FI (1) FI901145A0 (ko)
HU (1) HUT58039A (ko)
IL (1) IL93589A0 (ko)
MC (1) MC2104A1 (ko)
NO (1) NO901058L (ko)
PT (1) PT93348A (ko)
ZA (1) ZA901550B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9124512D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel compounds
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052963B1 (en) * 1980-11-20 1985-02-20 Beecham Group Plc Secondary amines
WO1984000956A1 (en) * 1982-08-27 1984-03-15 Beecham Group Plc Secondary arylethanolamines
EP0198412B1 (de) * 1985-04-16 1989-03-22 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Phenäthanolaminderivate

Also Published As

Publication number Publication date
EP0386603A3 (de) 1991-04-24
JPH02279659A (ja) 1990-11-15
FI901145A0 (fi) 1990-03-07
PT93348A (pt) 1990-11-07
HU901260D0 (en) 1990-05-28
HUT58039A (en) 1992-01-28
CA2010638A1 (en) 1990-09-07
NO901058L (no) 1990-09-10
IL93589A0 (en) 1990-12-23
ZA901550B (en) 1990-11-28
EP0386603A2 (de) 1990-09-12
MC2104A1 (fr) 1991-03-11
AU5061490A (en) 1990-09-13
NO901058D0 (no) 1990-03-06

Similar Documents

Publication Publication Date Title
PT82610B (pt) Processo para a preparacao de tiazolidino-dionas hipoglicemicas
FI953467A0 (fi) Aminohappojohdannaisia, näitä yhdisteitä sisältävät lääkeaineet ja menetelmä niiden valmistamiseksi
DE59010810D1 (de) Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
KR970027098A (ko) 프로피오페논 유도체 및 이의 제조 방법
MC2094A1 (fr) Medicament contenant de l'acide dihydrolipoique en tant que substance active,procede de preparation
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
DE3866408D1 (de) Selbstklebende vorrichtung zur transdermalen verabreichung eines wirkstoffs.
DE69100436D1 (de) Kalzitonin enthaltende emulsion zur nasalen verabreichung.
KR880007060A (ko) 제약 조성물
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
KR900014308A (ko) 비스펜에탄올아민
KR960003729A (ko) 항과혈당증 작용을 지닌 약제
IE872299L (en) Phenylethanolamine derivatives
KR920018076A (ko) 신규 폴리펩티드
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
HK80788A (en) Guanidines,process for their preparation,pharmaceutical preparations containing such compounds and their application
EP0005733B1 (en) Pharmaceutical compositions for use in the treatment of diabetic nephropathy and method for preparing them
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
KR880003623A (ko) 시알로실글리세로리피드로 된 신경장해질환 치료제
KR910015297A (ko) 오메프라졸 경구용 약제와 그 제조방법
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
KR890001582A (ko) 향류머티스제

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid